A new study published in PLOS ONE sheds light on the experiences of inpatient cancer care in Vietnam and identifies predictors of patient satisfaction.
The cross-sectional study, conducted between June and July 2022, involved 300 adult cancer patients receiving inpatient care at a major urban oncological hospital in Vietnam. The team used multivariable linear regression analyses to explore the associations between patient experiences and overall satisfaction ratings with oncological care.
The study revealed a high level of satisfaction among participants, with an average rating of 8.82 out of 10 and nearly all (98%) recommending the facility to their loved ones. Patient-centered communication, including effective interaction with nurses and doctors, and education about managing cancer medications were identified as key factors contributing to satisfaction.
However, the study also highlighted significant barriers. Delays in treatment scheduling emerged as a major concern, impacting overall satisfaction. Patients also reported challenges related to income loss, fear, anxiety, and concerns about treatment affordability, transportation, and lengthy wait times.
“Our findings emphasize the importance of prioritizing patient-centered communication and education about managing cancer medications to improve the inpatient experience,” says PhD candidate Thinh Vu. “Furthermore, raising awareness about treatment options, integrating mental health support into cancer care, and addressing identified barriers can significantly reduce patient distress and improve satisfaction with treatment processes.”
Vu’s dedication to improving cancer care in Vietnam is noteworthy. He is the first recipient of the prestigious Cancer Epidemiology Education in Special Populations (CEESP) fellowship for two consecutive years to conduct this research since 2006. His commitment was further recognized with the Cancer Public Health Student Award at the American Public Health Association Conference 2023; and Emerging Public Health Professional Award 2023 and an induction to Hall of Fame at UCLA Fielding School of Public Health. His study lays the groundwork for future research and interventions aimed at enhancing the quality of cancer care and patient experiences in Vietnam and beyond.